PI 3-kinase p110β Antibody (B-5): sc-376412. Western blot analysis of PI 3-kinase p110β expression in K-562 (A), RAW 264.7 (B), AMJ2-C8 (C), LADMAC (D) and RBL-1 (E) whole cell lysates and rat cerebellum tissue extract (F).
Not CRISPR data: the image illustrates antibody quality for visualizing CRISPR experiment results.
PI 3-kinase p110β Antibody (B-5): sc-376412. Western blot analysis of PI 3-kinase p110β expression in K-562 (A), RAW 264.7 (B), AMJ2-C8 (C), LADMAC (D) and RBL-1 (E) whole cell lysates and rat cerebellum tissue extract (F).
Not CRISPR data: the image illustrates antibody quality for visualizing CRISPR experiment results.
PI 3-kinase p110β Double Nickase Plasmid (m): sc-428980-NIC
20 µg of transfection-ready, purified plasmid DNA; Suitable for up to 20 transfections
PI 3-kinase p110β Double Nickase Plasmid (m) consists of a pair of plasmids each encoding a D10A mutated Cas9 nuclease and a target-specific 20 nt guide RNA (gRNA) designed to knockout gene expression with greater specificity than its CRISPR/Cas9 KO counterpart
Paired gRNA sequences are offset by approximately 20 bp to allow for specific Cas9-mediated double nicking of the genomic DNA, which mimics a DSB
One plasmid in the pair contains a puromycin-resistance gene for selection; the other plasmid in the pair contains a GFP marker to visually confirm transfection
PI 3-kinase p110β Double Nickase Plasmid (m) and PI 3-kinase p110β Double Nickase Plasmid (m2) encode distinct paired gRNA designs targeting Pik3cb. One or both designs may be available
Following transfection, gene knockout efficiency can be assayed by WB, IF or IHC using antibody: PI 3-kinase p110β Antibody (C-8): sc-376641